We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
Out of stock
This item is currently unavailable
Gone for 320 days. Could come back at any time — we're watching for you.
Out of stock 320 days · last price £790
The 2025-2030 World Outlook for Esophagus-Targeting Smart Pills
One email. No newsletter. No nudges.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 584 days · 584 data points (no recent data)
Historical
Generating forecast…
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
↑ Price chart
when this has been cheap or pricey
when this has been cheap or pricey
↑ Forecast
where the price is heading next
where the price is heading next
↓ Statistics
all-time high & low, recent range
all-time high & low, recent range
↑ Price alert
name your number, we'll email you
name your number, we'll email you
Price Distribution
Price distribution over 584 days • 1 price levels
Price Analysis
Most common price: £790 (584 days, 100.0%)
Price range: £790 - £790
Price levels: 1 different prices over 584 days
Description
This study covers the world outlook for esophagus-targeting smart pills across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of esophagus-targeting smart pills as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include CapsoVision, Check-Cap, Hq, IntroMedic, Jinshan Science & Technology (Group) Company, Koninklijke Philips, Medtronic, Olympus Corporation, Proteus Digital Health, and RF Company. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).
Product Specifications
- Format
- paperback
- ASIN
- B0CZ2C9Y15
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 03 March 2024
- Listed Since
- 23 April 2024
Similar Products You Might Like
96% match
The 2026-2031 World Outlook for Ingestible Smart Pills
£885.00
26 Aug 2026
96% match
The 2025-2030 World Outlook for Dysphagia Management Drugs
Price unavailable
96% match
The 2023-2028 World Outlook for Powder-Thickening Dysphagia Supplements
Price unavailable
96% match
The 2025-2030 World Outlook for Smart Pills Diagnostics
Price unavailable
95% match
The 2026-2031 World Outlook for Smart Pills Technologies
£885.00
19 Sep 2026
95% match
The 2023-2028 Outlook for Dysphagia Management Drugs in the United States
£520.00
18 Sep 2026
95% match
The 2023-2028 Outlook for Dysphagia Management Drugs in India
£515.00
06 Sep 2026
95% match
2021-2026 World Outlook for Smart Pills Drug Delivery
£795.00
01 Oct 2026
95% match
The 2023-2028 World Outlook for Dysphagia Management Drugs
£795.00
11 Sep 2026
95% match
The 2023-2028 Outlook for Dysphagia Management Drugs in China
£495.00
11 Sep 2026
95% match
The 2023-2028 Outlook for Dysphagia Management Drugs for US Zip Codes
£490.00
05 Sep 2026
95% match
The 2026-2031 World Outlook for Smart Pills
£885.00
01 Oct 2026
95% match
Esophageal Disorders: Diagnosis and Treatment
Springer
£99.63
03 Oct 2026
95% match
The 2025-2030 World Outlook for Precision Medicines
Price unavailable
95% match
The 2025-2030 World Outlook for Post-Marketing Pharmacovigilance and Medical Information
Price unavailable
95% match
Esophageal Abnormalities
IntechOpen
£114.00
18 Sep 2026
95% match
The 2025-2030 World Outlook for Pharmaceutical Contract Development and Manufacturing
Price unavailable
95% match
Risk Factors and Therapy of Esophagus Cancer
Springer
£95.74
18 Sep 2026
95% match
Risk Factors and Therapy of Esophagus Cancer
Springer
£73.69
01 Oct 2026
95% match
The 2025-2030 World Outlook for Digestive Health Supplements
Price unavailable
95% match
Esophageal Diseases: Diagnosis and Treatment
£90.19
09 Sep 2026
95% match
The 2025-2030 World Outlook for Prefilled Syringes Drug Molecules
Price unavailable
94% match
The 2025-2030 World Outlook for Enterprise Application Solution Services
Price unavailable
94% match